IN2015DN01855A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN01855A IN2015DN01855A IN1855DEN2015A IN2015DN01855A IN 2015DN01855 A IN2015DN01855 A IN 2015DN01855A IN 1855DEN2015 A IN1855DEN2015 A IN 1855DEN2015A IN 2015DN01855 A IN2015DN01855 A IN 2015DN01855A
- Authority
- IN
- India
- Prior art keywords
- subject
- micrornas
- colorectal
- suffering
- expression pattern
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 abstract 5
- 230000009826 neoplastic cell growth Effects 0.000 abstract 5
- 108700011259 MicroRNAs Proteins 0.000 abstract 4
- 239000012472 biological sample Substances 0.000 abstract 4
- 206010009944 Colon cancer Diseases 0.000 abstract 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract 3
- 230000014509 gene expression Effects 0.000 abstract 3
- 238000001514 detection method Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108091050874 miR-19a stem-loop Proteins 0.000 abstract 2
- 108091086850 miR-19a-1 stem-loop Proteins 0.000 abstract 2
- 108091088468 miR-19a-2 stem-loop Proteins 0.000 abstract 2
- 108091037787 miR-19b stem-loop Proteins 0.000 abstract 2
- 239000000090 biomarker Substances 0.000 abstract 1
- 108091031326 miR-15b stem-loop Proteins 0.000 abstract 1
- 230000002018 overexpression Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161550148P | 2011-10-21 | 2011-10-21 | |
| PCT/IB2012/003035 WO2013093635A2 (en) | 2011-10-21 | 2012-10-20 | Plasma micrornas for the detection of early colorectal cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01855A true IN2015DN01855A (cs) | 2015-07-10 |
Family
ID=48136439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1855DEN2015 IN2015DN01855A (cs) | 2011-10-21 | 2012-10-20 |
Country Status (18)
| Country | Link |
|---|---|
| US (6) | US20130102487A1 (cs) |
| EP (2) | EP2768986B1 (cs) |
| JP (2) | JP6159727B2 (cs) |
| KR (2) | KR101912731B1 (cs) |
| CN (2) | CN104651521B (cs) |
| AU (1) | AU2012356317B2 (cs) |
| BR (2) | BR122015004941B1 (cs) |
| CA (1) | CA2852850C (cs) |
| DK (2) | DK2768986T3 (cs) |
| ES (2) | ES2688693T3 (cs) |
| HU (2) | HUE035614T2 (cs) |
| IN (1) | IN2015DN01855A (cs) |
| MX (2) | MX357119B (cs) |
| NO (1) | NO3051026T3 (cs) |
| PL (2) | PL2944700T3 (cs) |
| PT (2) | PT2944700T (cs) |
| RU (2) | RU2662975C1 (cs) |
| WO (1) | WO2013093635A2 (cs) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0309214A3 (en) | 1987-09-22 | 1990-03-14 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Fiber optical probe connector for physiologic measurement devices |
| WO2012103355A2 (en) | 2011-01-26 | 2012-08-02 | Cepheid | Methods of detecting lung cancer |
| US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| DE202013012824U1 (de) | 2012-09-04 | 2020-03-10 | Guardant Health, Inc. | Systeme zum Erfassen von seltenen Mutationen und einer Kopienzahlvariation |
| US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| EP3771745A1 (en) | 2013-12-28 | 2021-02-03 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| EP3108012A4 (en) | 2014-02-18 | 2017-10-11 | Baylor Research Institute | Mir-320e and colorectal cancer |
| KR20240023185A (ko) * | 2014-06-13 | 2024-02-20 | 도레이 카부시키가이샤 | 대장암의 검출 키트 또는 디바이스 및 검출 방법 |
| WO2016034715A2 (fr) * | 2014-09-05 | 2016-03-10 | Prestizia | Methode de prediction de l'evolution clinique du cancer colorectal |
| CN104313142B (zh) * | 2014-10-16 | 2016-02-03 | 上海交通大学医学院附属仁济医院 | miRNA-30a作为标记分子在制备诊断试剂中的用途 |
| CN104388541B (zh) * | 2014-10-21 | 2017-07-04 | 复旦大学附属肿瘤医院 | miR‑1914*和miR‑1915的用途 |
| CN104372004B (zh) * | 2014-12-04 | 2018-04-27 | 广东医学院 | 一个与心肌梗死易感相关的miR-27a基因单核苷酸多态位点的检测方法及其应用 |
| EP3268494B1 (en) * | 2015-03-09 | 2021-04-21 | Agency For Science, Technology And Research | Method of determining the risk of developing breast cancer by detecting the expression levels of micrornas (mirnas) |
| EP3147370A1 (en) | 2015-09-28 | 2017-03-29 | Rheinische Friedrich-Wilhelms-Universität Bonn | Exosomal microrna in serum as an indicator for the activation of brown and beige fat tissue (bat) |
| CN108603228B (zh) | 2015-12-17 | 2023-09-01 | 夸登特健康公司 | 通过分析无细胞dna确定肿瘤基因拷贝数的方法 |
| AU2017313455A1 (en) * | 2016-08-18 | 2019-12-12 | Samantha KHOURY | Biomarkers of oral, pharyngeal and laryngeal cancers |
| EP3327135A1 (en) * | 2016-11-28 | 2018-05-30 | Advanced Marker Discovery, S.L. | In vitro method for identifying colorectal adenomas or colorectal cancer |
| CN106950370A (zh) * | 2017-01-25 | 2017-07-14 | 上海市第十人民医院 | 血液微小核酸大肠癌诊断分子组合 |
| CN107254522A (zh) * | 2017-06-09 | 2017-10-17 | 中山大学附属第三医院 | miR‑664a‑5p的检测试剂在制备肝癌诊断试剂/试剂盒中的应用 |
| CN107236799B (zh) * | 2017-06-15 | 2020-06-09 | 昆明医科大学第六附属医院 | 一种肾纤维化miRNA标记物 |
| CN107326092B (zh) * | 2017-08-25 | 2021-07-20 | 深圳市恩普电子技术有限公司 | 大肠癌相关的miRNA作为生物标志物的应用及大肠癌检测试剂盒 |
| CN107746886B (zh) * | 2017-09-11 | 2019-10-01 | 朱伟 | 一种与结直肠癌辅助诊断相关的血浆miRNA标志物及其应用 |
| WO2019144183A1 (en) * | 2018-01-23 | 2019-08-01 | La Trobe University | Biomarkers of colorectal cancer |
| CA3090785A1 (en) | 2018-02-14 | 2019-08-22 | John Daniel Dobak Iii | Novel gene classifiers and uses thereof in non-melanoma skin cancers |
| CN110205367B (zh) * | 2018-02-28 | 2022-06-21 | 伽蓝（集团）股份有限公司 | 一种筛选保护皮肤细胞端粒的活性物的方法 |
| WO2019217478A1 (en) * | 2018-05-09 | 2019-11-14 | Dermtech, Inc. | Novel gene classifiers and uses thereof in autoimmune diseases |
| CN108753974B (zh) * | 2018-06-27 | 2022-05-06 | 深圳华大生命科学研究院 | 一种结直肠癌肿瘤标志物及其检测方法与装置 |
| CN109557311B (zh) * | 2018-12-13 | 2022-02-15 | 中南大学湘雅医院 | 结直肠癌诊断标志物及结直肠癌的检测产品及其应用 |
| KR102275465B1 (ko) * | 2019-01-18 | 2021-07-09 | 사회복지법인 삼성생명공익재단 | 전이성 대장암 치료물질 스크리닝 방법 |
| US20220145398A1 (en) * | 2019-03-11 | 2022-05-12 | The Chinese University Of Hong Kong | Mirna markers for colorectal cancer |
| AU2020315134A1 (en) * | 2019-07-15 | 2022-02-03 | Consorcio Centro De Investigación Biomédica En Red | Non-invasive method for the diagnosis or screening of colorectal cancer and/or pre-cancerous stage thereof |
| CN110438227A (zh) * | 2019-07-29 | 2019-11-12 | 广州中昱医学生物科技有限公司 | miR-17-92在结直肠癌诊断中的用途 |
| CN112080568A (zh) * | 2020-09-27 | 2020-12-15 | 扬州大学 | 一种与湖羊肌肉细胞增殖相关的miRNA标志物及其检测引物和应用 |
| JP7740733B2 (ja) * | 2021-08-31 | 2025-09-17 | 国立大学法人大阪大学 | ２型糖尿病・大腸がんを検査する方法 |
| CN116640862A (zh) * | 2021-09-08 | 2023-08-25 | 广东积因生物有限公司 | 引物及试剂盒 |
| CN113981096A (zh) * | 2021-11-30 | 2022-01-28 | 无锡市疾病预防控制中心 | 一种用于诊断结直肠癌的血浆miRNA标志物及其应用 |
| CN114672560B (zh) * | 2022-01-12 | 2025-09-26 | 北京艾克伦医疗科技有限公司 | 通过外泌体miRNA标志物鉴定结直肠癌状态的检测试剂盒和方法 |
| WO2023222927A2 (en) | 2022-05-20 | 2023-11-23 | Novigenix Sa | Biomarkers for colorectal neoplasia |
| CN119144728B (zh) * | 2024-11-19 | 2025-04-29 | 四川大学华西医院 | 原发性肝癌的MicroRNA标志物的引物、试剂盒和应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| GB0415277D0 (en) * | 2004-07-07 | 2004-08-11 | Colonix Ltd | Apparatus and method for sampling mucosal surfaces |
| US7939255B2 (en) | 2006-07-03 | 2011-05-10 | Catholic University Industry Academy Cooperation Foundation | Diagnostic methods for colorectal cancer |
| WO2008055158A2 (en) * | 2006-10-30 | 2008-05-08 | University Of South Alabama | Microrna as biomarker in cancer |
| JP5501766B2 (ja) | 2006-11-01 | 2014-05-28 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 肝細胞癌における生存および転移を予測するためのマイクロｒｎａ発現サイン |
| WO2009059026A1 (en) * | 2007-10-30 | 2009-05-07 | Veridex, Llc | Process for monitoring colorectal cancer |
| CN101424640B (zh) * | 2007-11-02 | 2012-07-25 | 江苏命码生物科技有限公司 | 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法 |
| US20090233297A1 (en) * | 2008-03-06 | 2009-09-17 | Elizabeth Mambo | Microrna markers for recurrence of colorectal cancer |
| JP2011520454A (ja) * | 2008-05-16 | 2011-07-21 | ベリデックス・エルエルシー | 結腸直腸癌を評価する方法及びかかる方法に使用するための組成物 |
| WO2010004562A2 (en) | 2008-07-09 | 2010-01-14 | Rosetta Genomics Ltd. | Methods and compositions for detecting colorectal cancer |
| EP3181705A1 (en) * | 2008-11-12 | 2017-06-21 | Caris Life Sciences Switzerland Holdings GmbH | Methods and systems of using exosomes for determining phenotypes |
| WO2010055487A2 (en) * | 2008-11-13 | 2010-05-20 | Koninklijke Philips Electronics N.V. | Compositions and methods for micro-rna expession profiling of colorectal cancer |
| WO2010126355A1 (en) * | 2009-04-29 | 2010-11-04 | Academisch Medisch Centrum Bij De Universiteit Van Amsterdam | Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure |
| EP2336353A1 (en) * | 2009-12-17 | 2011-06-22 | febit holding GmbH | miRNA fingerprints in the diagnosis of diseases |
| US20100317533A1 (en) | 2009-06-05 | 2010-12-16 | British Columbia Cancer Agency Branch | Biomarkers of cancer metastasis |
| WO2011012136A1 (en) | 2009-07-28 | 2011-02-03 | Exiqon A/S | A method for classifying a human cell sample as cancerous |
| CN101988060A (zh) * | 2009-07-30 | 2011-03-23 | 江苏命码生物科技有限公司 | 结直肠癌检测标记物及其检测方法、试剂盒和生物芯片 |
| TW201118178A (en) * | 2009-10-09 | 2011-06-01 | Baylor Res Inst | Identification of micrornas (miRNAs) in fecal samples as biomarkers for gastroenterological cancers |
| WO2011076147A1 (en) | 2009-12-24 | 2011-06-30 | Fudan University | Plasma-based micro-rna biomarkers and methods for early detection of colorectal cancer |
| WO2011076142A1 (en) | 2009-12-24 | 2011-06-30 | Fudan University | Compositions and methods for microrna expession profiling in plasma of colorectal cancer |
| CA2787027A1 (en) | 2010-01-13 | 2011-07-21 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Detection of gastrointestinal disorders |
| CN102985563A (zh) * | 2010-06-23 | 2013-03-20 | 香港中文大学 | 结肠直肠癌的微rna标志物 |
-
2009
- 2009-04-01 NO NO16160669A patent/NO3051026T3/no unknown
-
2012
- 2012-10-20 BR BR122015004941-5A patent/BR122015004941B1/pt active IP Right Grant
- 2012-10-20 IN IN1855DEN2015 patent/IN2015DN01855A/en unknown
- 2012-10-20 ES ES12852462.6T patent/ES2688693T3/es active Active
- 2012-10-20 BR BR112014009643-0A patent/BR112014009643B1/pt active IP Right Grant
- 2012-10-20 RU RU2015108970A patent/RU2662975C1/ru active
- 2012-10-20 MX MX2015002910A patent/MX357119B/es unknown
- 2012-10-20 DK DK12852462.6T patent/DK2768986T3/en active
- 2012-10-20 CN CN201510098369.5A patent/CN104651521B/zh active Active
- 2012-10-20 EP EP12852462.6A patent/EP2768986B1/en active Active
- 2012-10-20 CA CA2852850A patent/CA2852850C/en active Active
- 2012-10-20 ES ES15158185.7T patent/ES2662401T3/es active Active
- 2012-10-20 PL PL15158185T patent/PL2944700T3/pl unknown
- 2012-10-20 RU RU2014120427A patent/RU2611189C2/ru active
- 2012-10-20 HU HUE15158185A patent/HUE035614T2/en unknown
- 2012-10-20 US US13/656,690 patent/US20130102487A1/en not_active Abandoned
- 2012-10-20 JP JP2014536355A patent/JP6159727B2/ja active Active
- 2012-10-20 MX MX2014004810A patent/MX357550B/es active IP Right Grant
- 2012-10-20 KR KR1020157005756A patent/KR101912731B1/ko active Active
- 2012-10-20 DK DK15158185.7T patent/DK2944700T3/en active
- 2012-10-20 PT PT151581857T patent/PT2944700T/pt unknown
- 2012-10-20 EP EP15158185.7A patent/EP2944700B1/en active Active
- 2012-10-20 AU AU2012356317A patent/AU2012356317B2/en active Active
- 2012-10-20 CN CN201280064096.7A patent/CN104145024A/zh active Pending
- 2012-10-20 HU HUE12852462A patent/HUE039522T2/hu unknown
- 2012-10-20 PT PT12852462T patent/PT2768986T/pt unknown
- 2012-10-20 KR KR1020147013663A patent/KR101900872B1/ko active Active
- 2012-10-20 WO PCT/IB2012/003035 patent/WO2013093635A2/en not_active Ceased
- 2012-10-20 US US14/352,462 patent/US20150087525A1/en not_active Abandoned
- 2012-10-20 PL PL12852462T patent/PL2768986T3/pl unknown
-
2015
- 2015-03-05 JP JP2015043433A patent/JP6203209B2/ja active Active
- 2015-03-05 US US14/639,539 patent/US20150176082A1/en not_active Abandoned
-
2016
- 2016-06-14 US US15/181,578 patent/US20160289771A1/en not_active Abandoned
-
2018
- 2018-06-28 US US16/022,597 patent/US20180346996A1/en active Pending
- 2018-08-08 US US16/058,940 patent/US20180355439A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN01855A (cs) | ||
| NZ593514A (en) | p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer | |
| NZ607282A (en) | Method for using gene expression to determine prognosis of prostate cancer | |
| IN2013CN01129A (cs) | ||
| WO2010096154A3 (en) | Compositions and methods for diagnosis and prognosis of colorectal cancer | |
| HK1259001A1 (zh) | 癌症的预後和诊断方法 | |
| WO2012096545A3 (ko) | 췌장암 암줄기세포 특성을 이용한 췌장암 신규 바이오마커 및 그의 용도 | |
| EP4335932A3 (en) | Methods of monitoring conditions by sequence analysis | |
| WO2008008284A3 (en) | Cancer biomarkers and methods of use threof | |
| MX390772B (es) | Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias. | |
| WO2013062931A3 (en) | A molecular beacon based assay for the detection of biomarkers of breast cancer metastasis | |
| MX363201B (es) | Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico. | |
| NZ599456A (en) | Assays for the detection of anti-tnf drugs and autoantibodies | |
| WO2012027631A3 (en) | Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells | |
| MX2012007009A (es) | Método para diagnosticar un tumor maligno. | |
| WO2015091575A3 (en) | Different levels in blood cell samples of emt-markers for the diagnosis of cancer, in particular of colorectal (crc) and pancreatic (pc) cancer | |
| WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma | |
| GB201222576D0 (en) | Method for diagnosing lung cancer | |
| WO2014161910A3 (en) | Methods and arrays for use in biomarker detection for prostate cancer | |
| WO2010144808A3 (en) | Identification of dsg-3 as a biomarker for the detection of metastasis in lymph nodes | |
| MX2012000041A (es) | Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta. | |
| WO2012097207A3 (en) | Cytokine profiles as methods for diagnosis and prognosis of irritable bowel syndrome | |
| NZ605561A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| IL189185A0 (en) | Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system | |
| WO2009132257A3 (en) | Cytological methods for detecting cancer |